Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1978 1
1979 1
1985 1
1989 1
1991 1
1992 1
1994 2
1995 1
1996 1
2003 1
2007 1
2008 2
2011 1
2012 1
2016 1
2020 1
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
[Protective effects of d-chlorpheniramine maleate pre-treatment against acute side effects of Irinotecan(CPT- 11)].
Misumi N, Hiraike M, Nawata F, Hashimoto M, Tanigawa K, Takase I, Nabeshima A, Honda S. Misumi N, et al. Gan To Kagaku Ryoho. 2011 Jul;38(7):1149-53. Gan To Kagaku Ryoho. 2011. PMID: 21772100 Japanese.
To assess the protective effects of pre-treatment with d-CM on cholinomimetic side effects in the early stage after Irinotecan (CPT-11) administration, we prescribed d- Chlorpheniramine maleate (d-CM) to a group of patients prior to Irinotecan (CPT-11) admini …
To assess the protective effects of pre-treatment with d-CM on cholinomimetic side effects in the early stage after Irinotecan (CPT-11) admi …
In vitro and in vivo correlation for controlled-release formulation of d-chlorpheniramine maleate.
Katori N, Okudaira K, Aoyagi N, Takeda Y, Uchiyama M. Katori N, et al. J Pharmacobiodyn. 1991 Oct;14(10):567-75. doi: 10.1248/bpb1978.14.567. J Pharmacobiodyn. 1991. PMID: 1818098
Four commercial controlled-release tablets of d-chlorpheniramine maleate, which showed various drug release properties, were administered to beagle dogs, and the correlation between in vitro drug release and in vivo absorption was studied. ...
Four commercial controlled-release tablets of d-chlorpheniramine maleate, which showed various drug release properties, …
[Behavior of chlorpheniramine in vivo after administration of d- and l-chlorpheniramine maleate].
Fujiwara K, Iwamoto K, Kawai S, Sakamoto T. Fujiwara K, et al. Yakugaku Zasshi. 1989 Jan;109(1):59-64. doi: 10.1248/yakushi1947.109.1_59. Yakugaku Zasshi. 1989. PMID: 2732905 Japanese.
Plasma levels of I were determined by the HPLC method after oral administration of d-chlorpheniramine maleate (II) or l-chlorpheniramine maleate (III) to healthy subjects and dogs. ...
Plasma levels of I were determined by the HPLC method after oral administration of d-chlorpheniramine maleate (II) or l …
[Evaluation of short-time premedication with d-chlorpheniramine maleate injection for paclitaxel-induced hypersensitivity reaction].
Harada T, Doi M, Yamada Y, Akase T. Harada T, et al. Gan To Kagaku Ryoho. 2008 Aug;35(8):1347-51. Gan To Kagaku Ryoho. 2008. PMID: 18701846 Clinical Trial. Japanese.
Taking this situation into consideration, our hospital uses a short-time premedication method wherein d-Chlorpheniramine Maleate injections are substituted for diphenhydramine hydrochloride tablets, and the time required for premedication is reduced to 15 min …
Taking this situation into consideration, our hospital uses a short-time premedication method wherein d-Chlorpheniramine Ma …
Drug-induced hypersensitivity syndrome caused by minodronic acid hydrate.
Muto Y, Kuse N, Inomata M, Awano N, Tone M, Takada K, Fujimoto K, Bae Y, Kumasaka T, Izumo T. Muto Y, et al. BMC Pulm Med. 2021 Nov 7;21(1):350. doi: 10.1186/s12890-021-01709-x. BMC Pulm Med. 2021. PMID: 34743720 Free PMC article.
She noticed a generalized skin rash 44 days before admission and started oral betamethasone-d-chlorpheniramine maleate combination tablets for allergic dermatitis. ...
She noticed a generalized skin rash 44 days before admission and started oral betamethasone-d-chlorpheniramine maleate …
A potential association between myocardial ischemia and epinephrine for anaphylaxis.
Urushidani S, Kuriyama A. Urushidani S, et al. Am J Emerg Med. 2020 Jun;38(6):1297.e1-1297.e3. doi: 10.1016/j.ajem.2020.01.033. Epub 2020 Jan 18. Am J Emerg Med. 2020. PMID: 31983596
We initiated fluid resuscitation with Ringer's lactate solution; injected 0.3 mg epinephrine intramuscularly; and administered d-chlorpheniramine maleate 5 mg, famotidine 20 mg, and methylprednisolone 80 mg intravenously. ...
We initiated fluid resuscitation with Ringer's lactate solution; injected 0.3 mg epinephrine intramuscularly; and administered d-c …
Anaphylaxis in the operating room treated with an anaphylaxis response kit: A case report.
Shu A, Hoshi T, Hagiya K. Shu A, et al. Saudi J Anaesth. 2023 Jan-Mar;17(1):117-119. doi: 10.4103/sja.sja_631_22. Epub 2023 Jan 2. Saudi J Anaesth. 2023. PMID: 37032664 Free PMC article.
Once the blood pressure normalized, we administered hydrocortisone, famotidine, and d-chlorpheniramine maleate. Thereafter, his condition stabilized, he recovered well, and he was discharged. ...
Once the blood pressure normalized, we administered hydrocortisone, famotidine, and d-chlorpheniramine maleate. Thereaf …
Evaluation of the local antihistaminic activity of dimetindene maleate by a quantitative method.
Rampini E, Oberhauser V, Nunzi E. Rampini E, et al. Dermatologica. 1978;157(2):105-9. doi: 10.1159/000250814. Dermatologica. 1978. PMID: 27397 Clinical Trial.
The topical application of a 0.1% dimetindene maleate gel on the forearms of 11 subjects reduces the areas of both erythema and wheal produced by the intradermal injection of 0.025 mg of histamine hydrochloride to a statistically greater degree than 1% d-chlorphe …
The topical application of a 0.1% dimetindene maleate gel on the forearms of 11 subjects reduces the areas of both erythema and wheal …
Comparative study of SCH 434 and CTM-D in the treatment of seasonal allergic rhinitis.
Prevost M, Turenne Y, Moote DW, Mazza J, Clermont A, PetitClerc C, Danzig MR. Prevost M, et al. Clin Ther. 1994 Jan-Feb;16(1):50-6. Clin Ther. 1994. PMID: 7911402 Clinical Trial.
Patients were randomly assigned to receive either SCH 434 (loratadine 5 mg and pseudoephedrine sulfate 120 mg) or CTM-D (chlorpheniramine maleate 12 mg and pseudoephedrine sulfate 120 mg) twice daily for 2 weeks. ...In conclusion, the combination of loratadin …
Patients were randomly assigned to receive either SCH 434 (loratadine 5 mg and pseudoephedrine sulfate 120 mg) or CTM-D (chlorphen …
21 results